850
Views
1
CrossRef citations to date
0
Altmetric
Rotavirus – Research Article

Model-based estimation of the impact on rotavirus disease of RV3-BB vaccine administered in a neonatal or infant schedule

ORCID Icon, , , , , & show all
Article: 2139097 | Received 14 Apr 2022, Accepted 14 Oct 2022, Published online: 21 Nov 2022

References

  • Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatr. 2018;172(10):1–9. doi:10.1001/jamapediatrics.2018.1960.
  • International Vaccine Access Center. Viewhub report: global vaccine introduction and implementation. Baltimore, MD: Johns Hopkins Bloomberg School of Public Health; 2021. https://view-hub.org/sites/default/files/2021-11/VIEW-hub_Report_Sept2021.pdf
  • Lopman BA, Pitzer VE, Sarkar R, Gladstone B, Patel M, Glasser J, Gambhir M, Atchison C, Grenfell BT, Edmunds WJ, et al. Understanding reduced rotavirus vaccine efficacy in low socio-economic settings. PLoS One. 2012;7(8):e41720. doi:10.1371/journal.pone.0041720.
  • Lo Vecchio A, Liguoro I, Dias JA, Berkley JA, Boey C, Cohen MB, Cruchet S, Salazar-Lindo E, Podder S, Sandhu B, et al. Rotavirus immunization: global coverage and local barriers for implementation. Vaccine. 2017;35(12):1637–44. doi:10.1016/j.vaccine.2017.01.082.
  • Bines JE, At Thobari J, Satria CD, Handley A, Watts E, Cowley D, Nirwati H, Ackland J, Standish J, Justice F, et al. Human neonatal rotavirus vaccine (RV3-BB) to target rotavirus from birth. N Engl J Med. 2018;378(8):719–30. doi:10.1056/NEJMoa1706804.
  • Clark A, van Zandvoort K, Flasche S, Sanderson C, Bines J, Tate J, Parashar U, Jit M. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect Dis. 2019;19(7):717–27. doi:10.1016/S1473-3099(19)30126-4.
  • Clark A, Tate J, Parashar U, Jit M, Hasso-Agopsowicz M, Henschke N, Lopman B, Van Zandvoort K, Pecenka C, Fine P, et al. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. Lancet Global Health. 2019;7(11):e1541–52. doi:10.1016/S2214-109X(19)30412-7.
  • Pitzer VE, Atkins KE, de Blasio BF, Van Effelterre T, Atchison CJ, Harris JP, Shim E, Galvani AP, Edmunds WJ, Viboud C, et al. Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One. 2012;7(8):e42320. doi:10.1371/journal.pone.0042320.
  • Van Effelterre T, Soriano-Gabarro M, Debrus S, Claire Newbern E, Gray J. A mathematical model of the indirect effects of rotavirus vaccination. Epidemiol Infect. 2010;138(6):884–97. doi:10.1017/S0950268809991245.
  • Geard NM, McCaw JM, Dorin A, Korb KB, McVernon J. Synthetic population dynamics: a model of household demography. J Artif Soc Social Simul. 2013;16(1). doi:10.18564/jasss.2098.
  • Geard N, Glass K, McCaw JM, McBryde ES, Korb KB, Keeling MJ, McVernon J. The effects of demographic change on disease transmission and vaccine impact in a household structured population. Epidemics. 2015;13:56–64. doi:10.1016/j.epidem.2015.08.002.
  • Campbell PT, McVernon J, Geard N. Determining the best strategies for maternally targeted pertussis vaccination using an individual-based model. Am J Epidemiol. 2017;186(1):109–17. doi:10.1093/aje/kwx002.
  • Linhares AC, Gabbay YB, Freitas RB, da Rosa ES, Mascarenhas JD, Loureiro EC. Longitudinal study of rotavirus infections among children from Belem, Brazil. Epidemiol Infect. 1989;102(1):129–45. doi:10.1017/S0950268800029769.
  • Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, Glass RI, Estes MK, Pickering LK, Ruiz-Palacios GM. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022–28. doi:10.1056/NEJM199610033351404.
  • de Blasio BF, Kasymbekova K, Flem E. Dynamic model of rotavirus transmission and the impact of rotavirus vaccination in Kyrgyzstan. Vaccine. 2010;28(50):7923–32. doi:10.1016/j.vaccine.2010.09.070.
  • Pitzer VE, Viboud C, Simonsen L, Steiner C, Panozzo CA, Alonso WJ, Miller MA, Glass RI, Glasser JW, Parashar UD, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science. 2009;325(5938):290–94. doi:10.1126/science.1172330.
  • Ward RL, Bernstein DI, Shukla R, Young EC, Sherwood JR, McNeal MM, Walker MC, Schiff GM. Effects of antibody to rotavirus on protection of adults challenged with a human rotavirus. J Infect Dis. 1989;159(1):79–88. doi:10.1093/infdis/159.1.79.
  • Wilde J, Yolken R, Willoughby R, Eiden J. Improved detection of rotavirus shedding by polymerase chain reaction. Lancet. 1991;337(8737):323–26. doi:10.1016/0140-6736(91)90945-L.
  • Koopman JS, Monto AS, Longini IM Jr. The Tecumseh study. XVI: family and community sources of rotavirus infection. Am J Epidemiol. 1989;130(4):760–68. doi:10.1093/oxfordjournals.aje.a115397.
  • Chiba S, Yokoyama T, Nakata S, Morita Y, Urasawa T, Taniguchi K, Urasawa S, Nakao T. Protective effect of naturally acquired homotypic and heterotypic rotavirus antibodies. Lancet. 1986;2(8504):417–21. doi:10.1016/S0140-6736(86)92133-1.
  • Lopman B, Vicuna Y, Salazar F, Broncano N, Esona MD, Sandoval C, Gregoricus N, Bowen MD, Payne D, Vaca M, et al. Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador. PLoS One. 2013;8(7):e67763. doi:10.1371/journal.pone.0067763.
  • Patel MM, Pitzer VE, Alonso WJ, Vera D, Lopman B, Tate J, Viboud C, Parashar UD. Global seasonality of rotavirus disease. Pediatr Infect Dis J. 2013;32(4):e134–147. doi:10.1097/INF.0b013e31827d3b68.
  • Balcan D, Gonçalves B, Hu H, Ramasco JJ, Colizza V, Vespignani A. Modeling the spatial spread of infectious diseases: the global epidemic and mobility computational model. J Comput Sci. 2010;1(3):132–45. doi:10.1016/j.jocs.2010.07.002.
  • Senturia YD. Epidemiology of rotavirus gastroenteritis. J Epidemiol Community Health. 1986;40(3):236–39. doi:10.1136/jech.40.3.236.
  • Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, Jaffar S, Gomara MI, Gray JJ, Brown DW, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011;365(4):337–46. doi:10.1056/NEJMoa1006261.
  • GBD Diarrhoeal Diseases Collaborators. Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017;17(9):909–48. doi:10.1016/S1473-3099(17)30276-1.
  • Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P. Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis. PLoS One. 2009;4(6):e6060. doi:10.1371/journal.pone.0006060.
  • Debellut F, Clark A, Pecenka C, Tate J, Baral R, Sanderson C, Parashar U, Kallen L, Atherly D. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 GAVI countries: a modelling study. Lancet Global Health. 2019;7(12):e1664–74. doi:10.1016/S2214-109X(19)30439-5.
  • Herliana P, Douiri A. Determinants of immunisation coverage of children aged 12-59 months in Indonesia: a cross-sectional study. BMJ Open. 2017;7(12):e015790. doi:10.1136/bmjopen-2016-015790.
  • Bennett A, Pollock L, Bar-Zeev N, Lewnard JA, Jere KC, Lopman B, Iturriza-Gomara M, Pitzer VE, Cunliffe NA. Community transmission of rotavirus infection in a vaccinated population in Blantyre, Malawi: a prospective household cohort study. Lancet Infect Dis. 2021;21(5):731–40. doi:10.1016/S1473-3099(20)30597-1.
  • Anderson EJ, Shippee DB, Weinrobe MH, Davila MD, Katz BZ, Reddy S, Cuyugan MG, Lee SY, Simons YM, Yogev R, et al. Indirect protection of adults from rotavirus by pediatric rotavirus vaccination. Clin Infect Dis. 2013;56(6):755–60. doi:10.1093/cid/cis1010.
  • Otero CE, Langel SN, Blasi M, Permar SR. Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries. PLoS Pathog. 2020;16(11):e1009010. doi:10.1371/journal.ppat.1009010.
  • Chen MY, Kirkwood CD, Bines J, Cowley D, Pavlic D, Lee KJ, Orsini F, Watts E, Barnes G, Danchin M. Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand. Hum Vaccin Immunother. 2017;13(5):1126–35. doi:10.1080/21645515.2016.1274474.
  • Parker EPK, Bronowski C, Sindhu KNC, Babji S, Benny B, Carmona-Vicente N, Chasweka N, Chinyama E, Cunliffe NA, Dube Q, et al. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants. Nat Commun. 2021;12(1):7288. doi:10.1038/s41467-021-27074-1.
  • Campbell PT, McVernon J, McIntyre P, Geard N. Influence of population demography and immunization history on the impact of an antenatal pertussis program. Clin Infect Dis. 2016;63(suppl_4):S213–20. doi:10.1093/cid/ciw520.
  • Cates JE, Amin AB, Tate JE, Lopman B, Parashar U. Do rotavirus strains affect vaccine effectiveness? A systematic review and meta-analysis. Pediatr Infect Dis J. 2021;40(12):1135–43. doi:10.1097/INF.0000000000003286.